Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1a inhibition in hepatocellular carcinoma.

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1a inhibition in hepatocellular carcinoma. Hepatology. 2013 May; 57(5):1847-57.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.